tm logo

Monitor this mark

View On USPTO

APTAD
Live/Registered
REGISTERED

on 01 Jun 2021

Last Applicant/ Owned by

Dialectic Therapeutics, Inc.

12200 N. Stemmons Fwy., Suite 100

Dallas

TX

75234

Serial Number

90009062 filed on 18th Jun 2020

Registration Number

6368207 registered on 01st Jun 2021

in the Principal Register

Correspondent Address

Daniel Denton

Daniel Denton

P.O. 670688

DALLAS TX 75367

Filing Basis

1. use application currently

Disclaimer

NO DATA

APTAD

Pharmaceutical products development, namely, development of pharmaceuticals in the field of oncology that target the degradation of anti-apoptotic cellular proteins

Classification Information

Class [042]
Computer & Software Services & Scientific Services

Pharmaceutical products development, namely, development of pharmaceuticals in the field of oncology that target the degradation of anti-apoptotic cellular proteins

First Use Date in General

13th Feb 2020

First Use Date in Commerce

13th Feb 2020

Mark Details

Serial Number

No 90009062

Mark Type

No Service Mark

Attorney Docket Number

No DIAL-M001US

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
01st Jun 2021REGISTERED-PRINCIPAL REGISTER
16th Mar 2021PUBLISHED FOR OPPOSITION
16th Mar 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
24th Feb 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
06th Feb 2021APPROVED FOR PUB - PRINCIPAL REGISTER
20th Jan 2021TEAS/EMAIL CORRESPONDENCE ENTERED
20th Jan 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
07th Jan 2021ASSIGNED TO LIE
29th Sep 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
22nd Sep 2020NON-FINAL ACTION WRITTEN